Best of ASCO - 2014 Annual Meeting




Head and Neck Cancer

2018 ASCO Annual Meeting

Sort by: title abstract no. first author
A double-blind, randomized pilot study of NS-21 in the prevention of radiation dermatitis for patients with head and neck cancer.

Chen-Hsi Hsieh


A novel method of intra-arterial chemotherapy for oral cancer.

Masatoshi Ohmae


A phase I dose-finding study of metformin in combination with concurrent cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma.

Shuchi Gulati


A phase I study of the PI3K inhibitor buplarlisib (B) with concurrent chemoradiotherapy (CRT) in patients with high risk locally advanced squamous cell cancer of the head and neck (LASCCHN).

Jochen H. Lorch


A phase II randomized trial of pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN): First results of the GORTEC 2015-01 “PembroRad” trial.

Xu Shan Sun


A randomised, double-blind, placebo-controlled phase IIa trial of AMG319 given orally as neoadjuvant therapy in patients with human papillomavirus (HPV) positive and negative head and neck squamous cell carcinoma (HNSCC).

Christian H.H Ottensmeier


A retrospective analysis of adult head and neck rhabdomyosarcoma (HN RMS) from 1984-2017.

Shivali Barot


Adjuvant apatinib in nasopharyngeal carcinoma patients with residual Epstein-Barr virus DNA after curative radiotherapy: A phase IIa/IIb trial.

Jun Ma


Avelumab-cetuximab-radiotherapy (RT) versus standards of care (SoC) in locally advanced squamous cell carcinoma of the head and neck (SCCHN): Safety phase of the randomized trial GORTEC 2017-01 (REACH).

Yungan Tao


BEST OF: A phase III study assessing the best of radiotherapy (Intensity Modulated RadioTherapy, IMRT) compared to the best of surgery (Trans-Oral Surgery, TOS) in patients with T1-T2, N0 oropharyngeal squamous cell carcinoma (OPSCC).

Christian Simon


Capecitabine efficacy and safety in patients with locally advanced nasopharyngeal cancer: Retrospective study.

Reyad Dada


Cisplatin (CIS) versus cetuximab (CET) with definitive concurrent radiotherapy (RT) for head and neck squamous cell carcinoma (HNSCC): An analysis of veteran’s health data.

Joshua Bauml


Clinical characteristics and prognosis of nasopharyngeal carcinoma patients: A report of 479 cases.

Jingjing Zhang


De-escalation in HPV-negative locally advanced head and neck squamous cell cancer (LA-HNSCC) in patients after induction chemotherapy: A retrospective case series.

Ryan J. Brisson


Definitive cetuximab-based (CRT-CX) vs. non-cetuximab based chemoradiation (CRT) in older patients with squamous cell carcinoma of the head and neck (HNSCC): Analysis of the SEER-Medicare linked database.

Dan Paul Zandberg


Diagnostic dilemma: Overlapping clinical and radiologic features of osteoradionecrosis and recurrent head and neck squamous cell carcinoma.

Andrea M Tufano


Differences in patterns of care in older vs. younger head and neck cancer patients.

Melissa Crawley


Evolution of induction chemotherapy in the pre- and post-taxane era for locally advanced laryngeal cancer: A National Cancer Data Base analysis.

Sagar Anil Patel


Impact of patient symptoms and caregiver tasks on psychological distress in caregivers for head and neck cancer (HNC).

Emily Castellanos


IMRT combined with concurrent S-1 chemotherapy for locally advanced nasopharyngeal carcinoma: A prospective phase II study.

Tao Lv


Influence of hypothyroidism post chemo radiation on outcomes in head and neck cancer.

Tanmoy Kumar Mandal


Long term efficacy and safety of nimotuzumab in unresectable locally advanced squamous cell carcinoma of head and neck: A real world Indian experience.

Sundaram Subramanian


Long-term outcomes for re-irradiation of recurrent head-and-neck cancers: Report of acute and long-term toxicity.

Nima Aghdam


Management of stage II nasopharyngeal carcinoma (NPC) in the US population: Retrospective analysis of the National Cancer Database (NCDB).

Omer Toor


Neck dissection rate in node positive human papillomavirus associated oropharyngeal carcinoma following chemoradiotherapy.

Sandro Porceddu


Neoadjuvant anti-OX40 (MEDI6469) prior to surgery in head and neck squamous cell carcinoma.

Richard Bryan Bell


New global prognosis score (GPSc) in resectable oral squamous cell carcinoma (OSCC): Joining up tumor and patient-related data.

Ursula Jariod-Ferrer


Outcomes of chemoradiation (CRT) for locoregionally advanced (LRA)squamous cell carcinoma of the head and neck (SCCHN): Outcomes with weekly cisplatin (WC) in an academic community based hospital.

Bruce Brockstein


Phase II study: Induction chemotherapy and transoral surgery as definitive treatment (Tx) for locally advanced oropharyngeal squamous cell carcinoma (OPSCC): A novel approach.

Robert S. Siegel


Phase II trial of high-dose melatonin oral gel for the prevention and treatment of oral mucositis in H&N cancer patients undergoing chemoradiation (MUCOMEL).

Alicia Lozano


Post-treatment evaluation of head and neck cancer patients in the era of advanced imaging and value-based care.

Thomas Hirsch


Preliminary toxicity data from the combination of pembrolizumab and definitive-dose radiotherapy for locally advanced head and neck cancer with contraindication to cisplatin therapy.

Jared Weiss


Quality of life (QoL) analysis in HPV positive oropharynx cancer (HPVOPC) patients in a randomized deintensification trial.

Michael Hwang


Regional lymph node metastases oncogenic mutations compared to primary tumors in HPV+ oropharynx patients.

John F. Deeken


Results of a randomized phase III study of nimotuzumab in combination with concurrent radiotherapy and cisplatin versus radiotherapy and cisplatin alone, in locally advanced squamous cell carcinoma of the head and neck.

Vijay Maruti Patil


Results of a randomized, placebo (PBO) controlled, double-blind P2b trial of GC4419 (avisopasem manganese) to reduce duration, incidence and severity and delay onset of severe radiation-related oral mucositis (SOM) in patients (pts) with locally advanced squamous cell cancer of the oral cavity (OC) or oropharynx (OP).

Carryn M. Anderson


Safety and effectiveness of transoral surgery for superficial head and neck cancer: The National Registration Survey of superficial head and neck cancer in Japan.

Chikatoshi Katada


Safety evaluation of nivolumab (Nivo) concomitant with cetuximab-radiotherapy for intermediate (IR) and high-risk (HR) local-regionally advanced head and neck squamous cell carcinoma (HNSCC): RTOG 3504.

Robert L. Ferris


Suboptimal regimens in sequential treatment (ST) with ICT (induction chemotherapy) followed by CCRT (concomitant chemotherapy) in "real life" patients with locally advanced pharyngo-laryngeal squamous-cell carcinoma (LAPLSCC) and prognosis.

Carmen Orte


The effect of MATE1 polymorphisms on cisplatin efficacy in patients with head and neck cancer.

Daniel Adam Breadner


The influence of age on treatment compliance and outcome in patients with stage IV head and neck cancer treated with radiotherapy and concurrent cisplatin or cetuximab.

Vittoria G. Espeli


The prognostic impact of level I lymph node involvement in oropharyngeal squamous cell carcinoma.

Roy Xiao


The retrospective analysis of nephrotoxicity for cisplatin dose of CRT compared 100mg/m2 to 80mg/m2 for head and neck cancer (HNC) patients.

Tomoyo Oguri


Treatment deintensification to surgery only for stage I human papillomavirus-associated oropharyngeal cancer.

John David Cramer


Treatments for locally advanced oropharyngeal cancer: A systematic review of clinical effectiveness and cost-effectiveness.

Chuong Ho


Tumour response and survival of treatment-naïve head and neck cancer patients treated with nimotuzumab: A systematic review and meta-analysis.

Sundaram Subramanian


Use of percutaneous endoscopic gastrostomy (PEG) tube feeding support in head and neck cancer patients.

Ramla Namisango Kasozi


Variations in the use of definitive chemoradiotherapy and immunoradiotherapy for patients with locally advanced head and neck cancer.

Shiva Kumar Reddy Mukkamalla